ANTIMICROBIAL THERAPY OF TUBERCULOSIS IN 1952
Authors: H C HINSHAW
Journal: Annals of Internal Medicine (1952)

Article1 August 1952ANTIMICROBIAL THERAPY OF TUBERCULOSIS IN 1952H. CORWIN HINSHAW, M.D., F.A.C.P.H. CORWIN HINSHAW, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-37-2-362 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt has become almost traditional to open a discussion of this topic with the statement that antimicrobial drugs have yielded disappointing results in treatment of tuberculosis, having failed to provide the long sought cure. Actually, physicians familiar with tuberculosis therapy have never anticipated that any antimicrobial drug would cure this disease. Instead of being disappointed, such physicians have been constantly revising their opinions toward greater optimism, especially within the past two years. They have found increasing utility for these drugs, particularly in the treatment of the more chronic and destructive types of tuberculosis, as progress has been made in deferring...Bibliography1. BogenOatway EWH: Chemotherapy for all active tuberculosis (correspondence), Am. Rev. Tuberc. 63: 490, 1951. MedlineGoogle Scholar2. D'EsopoRyanMedlar NDBJEM: Prolonged therapy with streptomycin—PAS; a clinical-pathological correlation, Trans. Tenth Conf. Chemotherapy of Tuberc. (Streptomycin Conference), 1951, Veterans Administration, Washington, D. C., p. 78. Google Scholar3. KarlsenPfuetzeCarrFeldmanHinshaw AGKHDTWHHC: The effect of combined therapy with streptomycin, para-aminosalicylic acid and promin on the emergence of streptomycin-resistant strains of tubercle bacilli, Proc. Staff Meet., Mayo Clin. 24: 85, 1949. MedlineGoogle Scholar4. TempelHughesMardisTowbinDye CWFJREMNWE: Combined intermittent regimens employing streptomycin and para-aminosalicylic acid in the treatment of pulmonary tuberculosis, Am. Rev. Tuberc. 63: 295, 1951. MedlineGoogle Scholar5. Lyght CE: Trans. Eleventh Conf. Chemotherapy of Tuberc., 1952, Veterans Administration, Washington, D. C. (In press.) Google Scholar6. O'ConnorChristieHowlett JBFJKS: Neurotoxicity of dihydrostreptomycin; effect of long term therapy, Am. Rev. Tuberc. 63: 312, 1951. MedlineGoogle Scholar7. LincolnHortonStokesMonroeRiggins NSRAMJHM: Dihydrostreptomycin in pulmonary tuberculosis, Am. Rev. Tuberc. 62: 572, 1950. MedlineGoogle Scholar8. LöfflerMoeschlin WS: Resultate der kombinierten Behandlung der Meningitis tuberculosa mit Streptomycin und Paraaminosalicylsäure (PAS) im Vergleich zur Behandlung mit Streptomycin allein, Schweiz. med. Wchnschr. 80: 365, 1950. MedlineGoogle Scholar9. ElmendorfCawthonMuschenheimMcDermott DFWDCW: The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (Nydrazid) in man, Am. Rev. Tuberc. 65: 429, 1952. MedlineGoogle Scholar10. RobitzekSelikoffOrnstein EHIJGG: Chemotherapy of human tuberculosis with hydrazine, Quart. Bull., Sea View Hosp. (Special Issue) 13: 27, 1952. MedlineGoogle Scholar11. HinshawThorenLynch HCMW: Unpublished observations. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: San Francisco, California*Presented at the Thirty-third Annual Session of the American College of Physicians, Cleveland, Ohio, April 25, 1952.From Stanford University School of Medicine, San Francisco, California. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 August 1952Volume 37, Issue 2Page: 362-366KeywordsAntimicrobialsDrug therapyDrugs ePublished: 1 December 2008 Issue Published: 1 August 1952 PDF downloadLoading ...